Close Menu

So Complex

Newsweek discusses some of "life's complexities," namely epigenetics and systems biology.

One article takes a look at epigenetics and its role in cancer. A few epigenetic cancer drugs have been approved by FDA, such as Vidaza and Zolinza, but "first-generation epigenetic drugs have not included a home run like Gleevec," the story says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Two researchers are calling for education for scientists on defending facts.

Researchers were among those who marched in London this weekend to call for another vote on Brexit.

Duke has agreed to pay $112.5 million to settle a lawsuit regarding its handling of data falsified by biologist Erin Potts-Kant. 

In PLOS this week: genetic factors influencing inorganic arsenic metabolism and toxicity, a germline variant in the cell adhesion molecule-coding gene DSCAM, and more.